The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pulmonary Alveolar Proteinosis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pulmonary Alveolar Proteinosis


High impact information on Pulmonary Alveolar Proteinosis


Chemical compound and disease context of Pulmonary Alveolar Proteinosis


Anatomical context of Pulmonary Alveolar Proteinosis


Gene context of Pulmonary Alveolar Proteinosis


Analytical, diagnostic and therapeutic context of Pulmonary Alveolar Proteinosis


  1. Diffuse progressive pulmonary interstitial and intra-alveolar cholesterol granulomas in childhood. Sato, K., Takahashi, H., Amano, H., Uekusa, T., Dambara, T., Kira, S. Eur. Respir. J. (1996) [Pubmed]
  2. Disseminated Mycobacterium kansasii infection with pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia. Goldschmidt, N., Nusair, S., Gural, A., Amir, G., Izhar, U., Laxer, U. Am. J. Hematol. (2003) [Pubmed]
  3. Metabolic lung disease: imaging and histopathologic findings. Chung, M.J., Lee, K.S., Franquet, T., Müller, N.L., Han, J., Kwon, O.J. European journal of radiology. (2005) [Pubmed]
  4. Pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia. Tsushima, K., Koyama, S., Saitou, H., Takematsu, H., Ichiyoshi, T., Kubo, K. Respiration; international review of thoracic diseases. (1999) [Pubmed]
  5. Therapeutic lung lavages in children and adults. Paschen, C., Reiter, K., Stanzel, F., Teschler, H., Griese, M. Respir. Res. (2005) [Pubmed]
  6. Lack of GM-CSF as a cause of pulmonary alveolar proteinosis. Hallman, M., Merritt, T.A. J. Clin. Invest. (1996) [Pubmed]
  7. Surfactant apoprotein-A concentration in sputum for diagnosis of pulmonary alveolar proteinosis. Masuda, T., Shimura, S., Sasaki, H., Takishima, T. Lancet (1991) [Pubmed]
  8. Immunoglobulin G is associated with surfactant protein A aggregate isolated from patients with pulmonary alveolar proteinosis. Hattori, A., Kuroki, Y., Takahashi, H., Sohma, H., Akino, T. Am. J. Respir. Crit. Care Med. (1997) [Pubmed]
  9. In vitro and in vivo transfer and expression of human surfactant SP-A- and SP-B-associated protein cDNAs mediated by replication-deficient, recombinant adenoviral vectors. Korst, R.J., Bewig, B., Crystal, R.G. Hum. Gene Ther. (1995) [Pubmed]
  10. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Wylam, M.E., Ten, R., Prakash, U.B., Nadrous, H.F., Clawson, M.L., Anderson, P.M. Eur. Respir. J. (2006) [Pubmed]
  11. Serum cholestenoic acid as a potential marker of pulmonary cholesterol homeostasis: increased levels in patients with pulmonary alveolar proteinosis. Meaney, S., Bonfield, T.L., Hansson, M., Babiker, A., Kavuru, M.S., Thomassen, M.J. J. Lipid Res. (2004) [Pubmed]
  12. Rapidly progressive pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia. Ito, K., Iwabe, K., Okai, T., Kouda, S., Tadokoro, M., Isiko, T. Intern. Med. (1994) [Pubmed]
  13. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF. Schoch, O.D., Schanz, U., Koller, M., Nakata, K., Seymour, J.F., Russi, E.W., Boehler, A. Thorax (2002) [Pubmed]
  14. Surfactant proteins A and D: disease markers. Kuroki, Y., Takahashi, H., Chiba, H., Akino, T. Biochim. Biophys. Acta (1998) [Pubmed]
  15. Interstitial lattice shadow and mediastinal lymphadenopathy with an elevation of carcinoembryonic antigen in severe pulmonary alveolar proteinosis. Usui, Y., Takayama, S., Nakayama, M., Miura, H., Kimula, Y. Intern. Med. (1992) [Pubmed]
  16. Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis. Latzin, P., Tredano, M., Wüst, Y., de Blic, J., Nicolai, T., Bewig, B., Stanzel, F., Köhler, D., Bahuau, M., Griese, M. Thorax (2005) [Pubmed]
  17. The immunoinhibitory activities of the lung lavage materials and sera from patients with pulmonary alveolar proteinosis (PAP). Stratton, J.A., Sieger, L., Wasserman, K. Journal of clinical & laboratory immunology. (1981) [Pubmed]
  18. Use of CT morphometry to detect changes in lung weight and gas volume. Perez, A., Coxson, H.O., Hogg, J.C., Gibson, K., Thompson, P.F., Rogers, R.M. Chest (2005) [Pubmed]
  19. Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage. Cheng, S.L., Chang, H.T., Lau, H.P., Lee, L.N., Yang, P.C. Chest (2002) [Pubmed]
WikiGenes - Universities